# Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder

> **NCT05463822** · EARLY_PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 15 (actual)

## Conditions studied

- Overactive Bladder
- Bladder, Overactive
- Urge Incontinence
- Urgency Urinary
- Urinary Frequency/Urgency

## Interventions

- **DRUG:** Transvaginal botulinum toxin A (BTA) injection

## Key facts

- **NCT ID:** NCT05463822
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2021-09-27
- **Final completion:** 2021-09-27
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05463822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05463822, "Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05463822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*